Overcoming intrinsic and acquired cetuximab resistance: an in vitro study on the potential of afatinib in HNSCC cell lines

被引:0
|
作者
De Pauw, Ines
Wouters, An
Van den Bossche, Jolien
Deschoolmeester, Vanessa
Pauwels, Patrick
Vermorken, Jan B.
Peeters, Marc
Lardon, Filip
机构
关键词
D O I
10.1158/1538-7445.AM2017-4102
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4102
引用
收藏
页数:2
相关论文
共 50 条
  • [11] Intrinsic and acquired resistance to CDK4/6 inhibitors and potential overcoming strategies
    Xu, Xia-qing
    Pan, Xiao-hui
    Wang, Ting-ting
    Wang, Jian
    Yang, Bo
    He, Qiao-jun
    Ding, Ling
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (02) : 171 - 178
  • [12] Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance
    O'Keefe, Rachel A.
    Bhola, Neil E.
    Lee, David S.
    Johnson, Daniel E.
    Grandis, Jennifer R.
    PLOS ONE, 2020, 15 (01):
  • [13] Overcoming Acquired Resistance to Afatinib in HCC827, a Non-small Cell Lung Cancer Cell Line
    Hsu, J.
    Lin, W.
    Lien, T.
    Chang, W.
    Sun, M.
    Jiang, S.
    Yen, K.
    Chao, Y.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 47 - 48
  • [14] Differential Cross resistance profiles of Head and Neck Carcinoma Cell lines with acquired resistance to Cisplatin and Cetuximab
    Niehr, F.
    Boyko-Fabian, M.
    Budach, V
    Tinhofer-Keilholz, I
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 13 - 14
  • [15] Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance
    Lucien Torlot
    Anna Jarzab
    Johanna Albert
    Ágnes Pók-Udvari
    Arndt Stahler
    Julian Walter Holch
    Marco Gerlinger
    Volker Heinemann
    Frederick Klauschen
    Thomas Kirchner
    Jörg Kumbrink
    Bernhard Küster
    Andreas Jung
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 669 - 682
  • [16] Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance
    Torlot, Lucien
    Jarzab, Anna
    Albert, Johanna
    Pok-Udvari, Agnes
    Stahler, Arndt
    Holch, Julian Walter
    Gerlinger, Marco
    Heinemann, Volker
    Klauschen, Frederick
    Kirchner, Thomas
    Kumbrink, Joerg
    Kuester, Bernhard
    Jung, Andreas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 669 - 682
  • [17] Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients
    Steven M. Bray
    Jeeyun Lee
    Seung Tae Kim
    Joon Young Hur
    Philip J. Ebert
    John N. Calley
    Isabella H. Wulur
    Thejaswini Gopalappa
    Swee Seong Wong
    Hui-Rong Qian
    Jason C. Ting
    Jiangang Liu
    Melinda D. Willard
    Ruslan D. Novosiadly
    Young Suk Park
    Joon Oh Park
    Ho Yeong Lim
    Won Ki Kang
    Amit Aggarwal
    Hee Cheol Kim
    Christoph Reinhard
    Scientific Reports, 9
  • [18] Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients
    Bray, Steven M.
    Lee, Jeeyun
    Kim, Seung Tae
    Hur, Joon Young
    Ebert, Philip J.
    Calley, John N.
    Wulur, Isabella H.
    Gopalappa, Thejaswini
    Wong, Swee Seong
    Qian, Hui-Rong
    Ting, Jason C.
    Liu, Jiangang
    Willard, Melinda D.
    Novosiadly, Ruslan D.
    Park, Young Suk
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Aggarwal, Amit
    Kim, Hee Cheol
    Reinhard, Christoph
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [19] Biomarkers of resistance to cetuximab in head and neck squamous cell carcinoma (HNSCC).
    Surikova, Ekaterina I.
    Kit, Oleg I.
    Neskubina, Irina V.
    Frantsiyants, Elena M.
    Vladimirova, Liubov Yu
    Lyanova, Aza A.
    Engibaryan, Marina A.
    Shalashnaya, Elena V.
    Aedinova, Irina V.
    Ulianova, Yulia V.
    Volkova, Viktoriya L.
    Pustovaya, Irina Viktorovna
    Ezhova, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [20] PTEN and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC).
    Da Costa, Alexandre Andre B. A.
    Costa, Felipe D'Almeida
    De Oliveira, Andrea Cruz Ferraz
    Stecca, Carlos
    Oliveira, Audrey
    Alves, Ana Caroline Fonseca
    Camandaroba, Marcos Pedro Guedes
    Araujo, Daniel Vilarim
    Machado, Larissa
    De Lima, Vladmir Claudio Cordeiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35